Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern] [Erratum]
Authors Huang L, Li G, Zhu J, Li Z, Li T, Leng X
Received 30 April 2020
Accepted for publication 30 April 2020
Published 12 May 2020 Volume 2020:13 Pages 4019—4020
Huang L, Li G, Zhu J, Li Z, Li T, Leng X. Onco Targets Ther. 2020;13:3289.
Due to a processing error the link for the British Medical Journal Open (BMJ Open) article described was missing.
The link for the BMJ Open article has been provided here: http://dx.doi.org/10.1136/bmjopen-2018-024473.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]